INOVIO PHARMACEUTICALS, INC. (INO) › Net IncomeINOVIO PHARMACEUTICALS, INC. (INO) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$24.41M2010: -$17.61M2011: -$15.25M2012: -$19.67M2013: -$66.03M2014: -$36.12M2015: -$29.19M2016: -$73.74M2017: -$88.21M2018: -$96.97M2019: -$119.36M2020: -$166.41M2021: -$303.66M2022: -$279.82M2023: -$135.12M2024: -$107.25M2025: -$84.95M-$84.95M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$84.95M+20.8%2024-$107.25M+20.6%2023-$135.12M+51.7%2022-$279.82M+7.9%2021-$303.66M-82.5%2020-$166.41M-39.4%2019-$119.36M-23.1%2018-$96.97M-9.9%2017-$88.21M-19.6%2016-$73.74M-152.6%2015-$29.19M+19.2%2014-$36.12M+45.3%2013-$66.03M-235.7%2012-$19.67M-29.0%2011-$15.25M+13.4%2010-$17.61M+27.8%2009-$24.41M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share